Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...

November 7, 2024 India's Lupin beats Q2 profit view on strong ... trade body says India's pharmaceutical export sales growth is expected to pick up to nearly 11% this fiscal year, from a roughly ...

Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...

Mumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the ...

Lupin secures a place in the prestigious S&P Global Sustainability Yearbook 2025: Our Bureau, Mumbai Thursday, February 27, ...

Ramesh Swaminathan, Executive Director, Global CFO, and Head of Corporate Affairs at Lupin, noted that India's pharmaceutical industry has diversified beyond the US.

Who are peers of Lupin Ltd? The peers of Lupin Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Mankind ...

The Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero.

This follows the final approval from the US FDA for its abbreviated new drug application (ANDA). Shares of Lupin Ltd ended at ...

Mumbai: Global pharma major Lupin Limited has announced its inclusion in prestigious S&P Global Sustainability Yearbook 2025, ...